Loading...
PRLD is not a good buy right now for an impatient trader. Price is trading below the key pivot (2.017) with bearish/weak momentum (MACD still below zero), and there are no proprietary Intellectia buy signals today to override that. Options positioning and insider buying are constructive, but without a near-term catalyst or a confirmed technical reversal, the risk/reward favors staying on the sidelines rather than buying immediately.
Trend/Momentum: Bearish-to-neutral. MACD histogram is negative (-0.0565) and still below zero, even though it’s contracting (selling pressure may be easing but not reversed). RSI(6)=37.38 is weak (not deeply oversold), consistent with a soft downtrend rather than a strong bounce setup. Moving averages are converging, suggesting consolidation after weakness rather than a clear uptrend. Key Levels: Pivot=2.017 is the near-term line in the sand. Resistance: R1=2.222 then R2=2.348. Support: S1=1.813 then S2=1.687. With the stock at ~1.915, it’s below pivot and closer to support than resistance—technically not an attractive “buy now” location unless you’re explicitly playing a support bounce. Pattern/Short-term stats: Similar-pattern analysis implies modest upside odds (70% chance of +0.52% next day, +3.68% next week, +6.26% next month), but that edge is small versus the current bearish bias.
Intellectia Proprietary Trading Signals

Insiders are Buying: insider buying amount increased ~188.46% over the last month, a supportive signal.
Options sentiment/flow: call-heavy positioning (low put/call ratios) and above-average activity can precede upside attempts.
Upcoming earnings event: QDEC 2025 earnings on 2026-02-16 (pre-market) can act as a catalyst if results/guidance surprise positively.
with MACD still negative; trend is not decisively bullish.
Latest reported quarter: 2025/Q3. Revenue grew to $6.5M (+116.67% YoY), showing strong top-line improvement off a small base. However, profitability weakened: Net income was -$19.73M (down -38.88% YoY, i.e., more negative), and EPS was -$0.26 (down -39.53% YoY). Gross margin was 100% (unchanged), but overall the company is still loss-making and cash-burn dynamics likely remain a key investor focus.
No analyst rating or price-target change data was provided, so a trend assessment (upgrades/downgrades and target revisions) cannot be determined from the dataset. Wall Street pros/cons view cannot be reliably summarized without those inputs.